Recombinant Human LRRC25/MAPA protein
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human LRRC25/MAPA protein is a Human Fragment protein, in the 21 to 165 aa range, expressed in HEK 293 cells, with >95%, < 0.1 EU/µg endotoxin level, suitable for SDS-PAGE, HPLC.
View Alternative Names
MAPA, UNQ6169/PRO20174, LRRC25, Leucine-rich repeat-containing protein 25, Monocyte and plasmacytoid-activated protein
Reactivity data
Product details
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The protein carries out functions connected to the innate immune system. LRRC25 is involved in modulating cellular responses to external stimuli like pathogens. It is a part of the complex responsible for the immune response working alongside Toll-like receptors. This involvement allows LRRC25 to participate actively in recognizing and responding to microbial infections suggesting its importance for immune activation.
Pathways
LRRC25 plays a role in signaling cascades such as the NF-kB pathway. Its interaction with proteins like MyD88 illustrates its role in signaling pathways leading to inflammation and immune responses. LRRC25 acts as a link between pathogen recognition and downstream transcriptional responses ensuring the proper defense mechanism of the cells.
Specifications
Form
Lyophilized
Additional notes
The purity of ab194037 was determined by SEC-HPLC and reducing SDS-PAGE.
General info
Function
Plays a role in the inhibition of RLR-mediated type I interferon signaling pathway by targeting RIGI for autophagic degradation. Interacts specifically with ISG15-associated RIGI to promote interaction between RIGI and the autophagic cargo receptor p62/SQSTM1 to mediate RIGI degradation via selective autophagy (PubMed : 29288164). Also plays a role in the inhibition of NF-kappa-B signaling pathway and inflammatory response by promoting the degradation of p65/RELA.
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com